654
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Previving: How Unaffected Women with a BRCA1/2 Mutation Navigate Previvor Identity

ORCID Icon, , , &
 

ABSTRACT

Receiving a positive result for a BRCA1/2 (BRCA) mutation – indicating a high lifetime risk to develop hereditary breast and ovarian cancer – can significantly alter a woman’s identity. BRCA-positive women who have not been diagnosed with cancer may be labeled “previvors,” which distinguishes those at-risk for developing cancer, but have not had cancer. Using semi-structured interviews (N = 25), this study explored how unaffected BRCA-positive women navigate the previvor identity. Women in this sample differed on their definitions of previvor, views of acceptance, rejection, or ambivalence toward the label, and identification as a previvor. Understanding how women interpret and embrace the previvor identity may help inform communication for those with BRCA genetic mutations, but whom have not been diagnosed with cancer.

Acknowledgments

The authors would like to thank the Facing Our Risk of Cancer Empowered (FORCE) community for their insight and contributions to this study.

Disclosure of potential conflicts of interest

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research was supported by an internal “New Researcher Grant” from the University of South Florida.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.